Back to Search
LUCAS SCHNELL, D.O.
D.O.
Orthopaedic Surgery Physician
NPI: 1245545565IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
DR.0054796(CO)
Adult Reconstructive Orthopaedic Surgery Physician
Orthopaedic Surgery — Adult Reconstructive Orthopaedic Surgery
Code: 207XS0114X
DR.0054796(CO)
Sports Medicine (Orthopaedic Surgery) Physician
Orthopaedic Surgery — Sports Medicine
Code: 207XX0005X
DR.0054796(CO)
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
KANSAS CITY UNIVERSITY OF PHYSICIANS AND SURGEONS
Class of 2009
Research & Publications (19)
Solute partitioning and filtration by extracellular matrices.
PMID 19587146·Am J Physiol Renal Physiol·2009
8-other
Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury.
PMID 19372269·Brain·2009
7-preclinical
Chronic spinal hemisection in rats induces a progressive decline in transmission in uninjured fibers to motoneurons.
PMID 19320005·Exp Neurol·2009
7-preclinical
Lamina-specific restoration of serotonergic projections after Nogo-A antibody treatment of spinal cord injury in rats.
PMID 18215231·Eur J Neurosci·2008
4-observational
Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans?
PMID 17479102·Nat Med·2007
7-preclinical
Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration.
PMID 16723516·J Neurosci·2006
4-observational
Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats.
PMID 16173073·Ann Neurol·2005
4-observational
Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord.
PMID 15689553·J Neurosci·2005
4-observational
Rapid induction of autoantibodies against Nogo-A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases.
PMID 14563689·FASEB J·2003
7-preclinical
Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions.
PMID 12843238·J Neurosci·2003
7-preclinical
Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury.
PMID 12718855·Neuron·2003
7-preclinical
Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group.
PMID 12610182·J Clin Oncol·2003
3-trial
Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats.
PMID 12571447·J Cereb Blood Flow Metab·2003
7-preclinical
Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury.
PMID 12379801·J Cell Biol·2002
7-preclinical
AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats.
PMID 11585624·J Neuroimmunol·2001
7-preclinical
Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice.
PMID 11141480·Am J Pathol·2001
7-preclinical
Reactions of oligodendrocytes to spinal cord injury: cell survival and myelin repair.
PMID 10833310·Exp Neurol·2000
7-preclinical
Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.
PMID 10667796·Nature·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 300 EXEMPLA CIR STE 200
LAFAYETTE, CO 80026 - Phone
- (303) 772-1600
Quick Facts
- NPI
- 1245545565
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 17
- Publications
- 19
Are you this provider?
Claim Your Profile